EmadA, MostafaviH, KhajedehlP.Effectiveness of adding alternate-day Theophylline to the treatment regimen of patients with moderate-to-severe asthma. Respir Care1996;41(6):520–523.
2.
KidneyJ, DominguezM, TaylorPM, ChungKF, BarnesPJ. Immuno-modulation by theophylline in asthma. Demonstration by withdrawal of therapy. Am J Respir Crit Care Med. 1995;151(6):1907–1914.
3.
WardAJM, McKenniffM, EvansJM, PageCP, CostelloJF. Theo-phylline an immunomodulatory role in asthma?Am Rev Respir Dis1993;147(3):518–523.
4.
PerssonCG. Overview of effects of theophylline. J Allergy Clin Immunol1986;78(4, Part 2):780–787.
5.
BarnesPJ, PauwelsRA. Theophylline in the management of asthma: time for reappraisal. Eur Respir J1994;7(3):579–591.
6.
SullivanP, BekirS, JaffarZ, PageC, JefferyP, CostelloJ.Anti-inflammatory effects of low-dose oral theophylline in atopic asthma. Lancet1994;343(8904):1006–1008. See the published erratum in Lancet 1994; 343(8911):1512.
7.
CalhounWJ, StevensCA, LambertSB. Modulation of superoxide production of alveolar macrophages and peripheral blood mononuclear cells by beta-agonists and theophylline. J Lab Clin Med1991;117(6):514–522.
8.
MascaliJJ, CrietusaP, NegriJ, BorishL.Anti-inflammatory effects of theophylline: modulation of cytokine production. Ann Allerg Asthma Immunol. In press.
9.
HolgateST, PortridgeMR. Compliance in asthma. Eur Respir Rev, 5, Review No. 26, April, 1995.
10.
RubinfeldAR, PainMCF. Perception of asthma. Lancet1976;1(7965):882–884.